The present study supports PRKCD to be a predictor for survival of CM patients, which is further supported by the high expression levels of PRKCD in CM tumor tissues than in the normal skin from the Oncomine gene expression database. This evidence concerns the gene PRKCD and cutaneous mastocytosis.